πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9649344

Methods and compositions for in vivo induction of pancreatic beta cell formation

The Board of Regents of the University of Texas System Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9649373

Neoseptins: small molecule adjuvants

The Board of Regents of the University of Texas System Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9645139

Neuroprotective chemicals and methods for identifying and using same

The Board of Regents of the University of Texas System Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9642859

Use of capsazepine and analogs thereof to treat cancer

The Board of Regents of the University of Texas System Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9638639

Plasmonic-magnetic bifunctional nanotubes for biological applications

The Board of Regents of the University of Texas System Β· Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9631041

PH-sensitive compositions for delivery of beta lapachone and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9629877

Human application of engineered chimeric antigen receptor (CAR) T-cells

The Board of Regents of the University of Texas System Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9630990

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

The Board of Regents of the University of Texas System Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9624211

Anti-cancer compounds

The Board of Regents of the University of Texas System Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9624484

Engineered primate L-methioninase for therapeutic purposes

The Board of Regents of the University of Texas System Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9616048

Anti-depression compounds

The Board of Regents of the University of Texas System Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9616076

Methods for treating viral infections using hydrogen sulfide donors

The Board of Regents of the University of Texas System Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9617511

Tissue-specific differentiation matrices and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9618521

Sperm-specific cation channel, Catsper2, and uses therefor

The Board of Regents of the University of Texas System Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9611292

Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction

The Board of Regents of the University of Texas System Β· Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9611266

Compounds and anti-tumor NQO1 substrates

The Board of Regents of the University of Texas System Β· Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9605057

Endotrophin neutralization and use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9598694

Micro-RNAs involved in macular degeneration

The Board of Regents of the University of Texas System Β· Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9592238

Anti-ceramide monoclonal antibody 2A2

The Board of Regents of the University of Texas System Β· Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9593131

Copper-cysteamine and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9585910

Polymers functionalized with ion-specific recognition elements

The Board of Regents of the University of Texas System Β· Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9579370

Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination

The Board of Regents of the University of Texas System Β· Granted Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9580690

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereo

The Board of Regents of the University of Texas System Β· Granted Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9574191

Selective inhibition of polyglutamine protein expression

The Board of Regents of the University of Texas System Β· Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted